MicroRNA-223 functions as an oncogene in human colorectal cancer cells

Oncology Reports

Volumn 32, Issue 1, 2014, Pages 115-120

  Zhang, Jufeng ^a   Luo, Xia ^b   Li, Huiming ^c   Yue, Xupeng ^e   Deng, Lin ^a   Cui, Yuanyuan ^d   Lu, Yanxin ^e  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^c SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; MicroRNA 223; Oncogene

Indexed keywords

MICRORNA 223; MICRORNA; MIRN223 MICRORNA, HUMAN;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER SCREENING; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; COHORT ANALYSIS; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; ONCOGENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION; CELL MOTION; COLORECTAL TUMOR; GENETICS; METABOLISM; PATHOLOGY; TISSUE MICROARRAY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; ONCOGENES; REAL-TIME POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS;

EID: 84903125214     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3173     Document Type: Article

References (39)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. Center MM, Jemal A and Ward E: International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 18: 1688-1694, 2009.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
4. Edwards BK, Ward E, Kohler BA, et al: Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116: 544-573, 2010.
5. Winter J, Jung S, Keller S, Gregory RI and Diederichs S: Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11: 228-234, 2009.
6. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
7. Qu J, Zhao L, Zhang P, et al: MicroRNA-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRNA. J Cell Physiol doi: 10.1002/jcp.24366, 2013 [Epub ahead of print].
8. Catania A, Maira F, Skarmoutsou E, D'Amico F, Abounader R and Mazzarino MC: Insight into the role of microRNAs in brain tumors (Review). Int J Oncol 40: 605-624, 2012.
9. Cherni I and Weiss GJ: miRNAs in lung cancer: large roles for small players. Future Oncol 7: 1045-1055, 2011.
10. Le Pennec S and Savagner F: MiRNAs in follicular thyroid tumors. Presse Med 40: 683-689, 2011 (In French).
11. Agostini M, Pucciarelli S, Calore F, Bedin C, Enzo M and Nitti D: miRNAs in colon and rectal cancer: a consensus for their true clinical value. Clin Chim Acta 411: 1181-1186, 2010.
12. Liu X, Zhang Z, Sun L, et al: microRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4. Carcinogenesis 32: 1798-1805, 2011.
13. He L and Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531, 2004. (Pubitemid 38868508)
14. Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714, 2009.
15. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
16. Corte H, Manceau G, Blons H and Laurent-Puig P: MicroRNA and colorectal cancer. Dig Liver Dis 44: 195-200, 2012.
17. Schetter AJ, Leung SY, Sohn JJ, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008. (Pubitemid 351185951)
18. Boni V, Zarate R, Villa JC, et al: Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. Pharmacogenomics J 11: 429-436, 2011.
19. Landi D, Gemignani F, Naccarati A, et al: Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 29: 579-584, 2008. (Pubitemid 351404875)
20. Laios A, O'Toole S, Flavin R, et al: Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 7: 35, 2008.
21. Gottardo F, Liu CG, Ferracin M, et al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392, 2007. (Pubitemid 47362758)
22. Mathé EA, Nguyen GH, Bowman ED, et al: MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 15: 6192-6200, 2009.
23. Li X, Zhang Y, Zhang H, et al: miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 9: 824-833, 2011.
24. Kang W, Tong JH, Chan AW, et al: Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer. PLoS One 7: e33919, 2012.
25. Mi S, Lu J, Sun M, et al: MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA 104: 19971-19976, 2007.
26. Miko E, Czimmerer Z, Csánky E, et al: Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res 35: 646-664, 2009.
27. Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G and Voros D: Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic signifi- cance. Mol Carcinog 52: 297-303, 2013.
28. Wong QW, Lung RW, Law PT, et al: MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 135: 257-269, 2008. (Pubitemid 351910680)
29. Sempere LF, Christensen M, Silahtaroglu A, et al: Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67: 11612-11620, 2007.
30. Xing J, Wan S, Zhou F, et al: Genetic polymorphisms in premicroRNA genes as prognostic markers of colorectal cancer. Cancer Epidemiol Biomarkers Prev 21: 217-227, 2012.
31. Lieberman DA: Clinical practice. Screening for colorectal cancer. N Engl J Med 361: 1179-1187, 2009.
32. Iorio MV and Croce CM: MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4: 143-159, 2012.
33. Motoyama K, Inoue H, Takatsuno Y, et al: Over- and underexpressed microRNAs in human colorectal cancer. Int J Oncol 34: 1069-1075, 2009.
34. Zhang J, Xiao Z, Lai D, et al: miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer. Br J Cancer 107: 352-359, 2012.
35. Monzo M, Navarro A, Bandres E, et al: Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res 18: 823-833, 2008.
36. Liu H, Zhu L, Liu B, et al: Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 316: 196-203, 2012.
37. Slaby O, Svoboda M, Fabian P, et al: Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402, 2007. (Pubitemid 351238155)
38. Ng EK, Tsang WP, Ng SS, et al: MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101: 699-706, 2009.
39. Chen X, Guo X, Zhang H, et al: Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28: 1385-1392, 2009.